Understanding the specificity requirements for GLP-1 and glucagon at GLP-1R and the glucagon receptor has enabled the design of a co-agonist peptide that eliminates obesity in a rodent model (Day et al ., 2009
MTA SHALL NOT BE LIABLE FOR ANY ADVERSE REACTIONS, SIDE EFFECTS, OR OUTCOMES RESULTING FROM MEDICATIONS PRESCRIBED BY PROVIDERS OR PREPARED BY PHARMACIES, NOR FOR ANY PROVIDER'S DECISION TO PRESCRIBE OR DECLINE TO PRESCRIBE TREATMENT
Answer- Absolutely
Zhang Y, Zhang Q, Bai Y, Zheng H, Ji L, Zhu X et al (2023) Glycogen synthesis kinase-3 involves in the analgesic effect of liraglutide on diabetic neuropathic pain
Additionally, make sure they offer alternative weight management medications/ solutions and can guide members who dont qualify for a GLP-1 toward other options
If you follow these tips and still feel tired, speak to your GP, healthcare provider or weight loss consultant